Matrix metalloproteinases are associated with severity of disease among COVID-19 patients: A possible pharmacological target.

Cavalcante, Gisele Lopes; Bonifacio, Lívia Pimenta; Sanches-Lopes, Jéssica Maria; Puga, Fernanda Guioti; de Carvalho, Felipe Santos; Bellissimo-Rodrigues, Fernando; Tanus-Santos, Jose Eduardo

Cavalcante, Gisele Lopes; Bonifacio, Lívia Pimenta; Sanches-Lopes, Jéssica Maria; Puga, Fernanda Guioti; de Carvalho, Felipe Santos; Bellissimo-Rodrigues, Fernando; Tanus-Santos, Jose Eduardo.

Affiliation

Cavalcante GL; Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil.
Bonifacio LP; Department of Social Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil.
Sanches-Lopes JM; Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil.
Puga FG; Department of Social Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil.
de Carvalho FS; Department of Medicine, Federal University of São Carlos, São Carlos, SP, Brazil.
Bellissimo-Rodrigues F; Department of Social Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil.
Tanus-Santos JE; Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil.

Basic Clin Pharmacol Toxicol ; 134(5): 727-736, 2024 May.

Article in En | MEDLINE | ID: mdl-38468413

Subject(s)
Key words

COVID19; TIMPs; matrix metalloproteinases

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tissue Inhibitor of Metalloproteinase-1 / COVID-19 Limits: Humans Language: En Journal: Basic Clin Pharmacol Toxicol Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2024 Document type: Article Affiliation country: Brasil Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google